Increasing Market Supply of Influenza Vaccines; 48 Batches of Quadrivalent Influenza Virus Split Vaccine Have Been Released
November 12, 2025
Source: drugdu
131
Southern Finance, November 11th - According to CLS (China Lianhe Securities), from Hualan Biological...According to sources, as of now, the company has approved and released influenza vaccines in 2025.54 batches of vaccines have been released, including 48 batches of quadrivalent influenza virus split vaccine. Since October, and especially November, public awareness of influenza vaccination has increased significantly, and the demand orders from disease control centers across the country have increased significantly compared to the same period last year. The company is increasing its market supply of influenza vaccines and will expedite the transportation of vaccines nationwide through cold chain systems after receiving orders from disease control centers across the country to meet the vaccination demand.
https://finance.eastmoney.com/a/202511113561078126.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Breaking the Mold and Forging a New Path! From Insulin Technology Pioneer to Global Innovation Competitor December 4, 2025
- A subsidiary of Kingfriend Pharmaceutical Co., Ltd. has received FDA approval for its self-developed injectable dapavancin December 4, 2025
- Major ophthalmic new drug successfully completed Phase III trials December 4, 2025
- Simcere Pharmaceutical and Wangshan Wangshui have reached an exclusive licensing agreement for deuterium remidevir hydrobromide for new indications such as RSV infection December 4, 2025
- SAL0140 tablets approved for clinical trials for the treatment of chronic kidney disease December 4, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
